SPIA
CBPO

Steward Partners Investment Advisory’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Steward Partners Investment Advisory’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-63
Closed -$6K – 1771
2017
Q1 		$6K Buy
+63
New +$6.73K ﹤0.01% 1102

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Steward Partners Investment Advisory's CBPO Position: Q2 2017 in Review

Steward Partners Investment Advisory sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 63 shares — an estimated $6K sold.

Steward Partners Investment Advisory first reported a position in CBPO in Q1 2017 and held it in 1 quarter. The position peaked at $6K in Q1 2017. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

  • Steward Partners Investment Advisory reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 63 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $6K.
  • Steward Partners Investment Advisory first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 1 quarter.
  • Steward Partners Investment Advisory's China Biologic Products Holdings, Inc. position peaked at $6K in Q1 2017.
  • 119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2017, filed 22 Nov 2017.